Intraperitoneal Hyperthermic Chemoperfusion (IPHC / HIPEC)

Intraperitoneal hyperthermic chemoperfusion (IPHC) is a specialized hyperthermia therapy used along with surgery
for treating advanced abdominal cancers. In this procedure, warmed anti-cancer drugs are circulated in the peritoneal cavity
for a limited period. Commonly used drugs include mitomycin-C and cisplatin.

IPHC is also known as HIPEC (Hyperthermic Intraperitoneal Chemotherapy),
intra-abdominal hyperthermic chemoperfusion, intraoperative chemohyperthermic peritoneal perfusion (CHPP),
or the Sugarbaker technique, after Dr. Paul Sugarbaker who pioneered this approach.

At Neuro Spinal Cancer Center, our specialized team performs this advanced procedure —
we are the only center in the Middle East & North Africa (MENA) offering such high-quality HIPEC treatment (besides Riyadh, KSA).
A multidisciplinary approach ensures individualized care and the best treatment outcomes.

Procedure Stages

1. Exploration: The surgeon opens the abdomen to evaluate peritoneal cancer.
2. Debulking (Cytoreduction): Visible tumor implants are removed. Even after removal, microscopic cancer cells may remain.
3. Chemoperfusion: The abdominal cavity is rinsed with a heated chemotherapy solution.
   Unlike systemic chemotherapy, HIPEC delivers high drug concentration locally, minimizing toxicity and side effects.

Points of Interest to Patients

• Peritoneal carcinomatosis
• Pseudomyxoma peritonei
• Mucinous adenocarcinoma of appendix
• Colorectal cancer with local infiltration
• Mesothelioma & pleural mesothelioma
• Gastric carcinomatosis
• HIPEC & CRS (Cytoreductive Surgery)
• Hyperthermic chemotherapy
• Debulking surgery
• Clinical trials
• Low-grade sarcoma
• Ovarian carcinomatosis
• Multidisciplinary team (MDT) management
• Intraoperative ultrasound
• Genomic profiling
• Center of Excellence in peritonectomy
• Chemotherapy infusion & staged procedures
• Adhesiolysis
• Risk and complications counseling

Pictures of Recently Performed Surgeries

Please click on the text to view:

• Appendix tumor in peritoneal surface malignancy.
• Cleaning the peritoneal implant after Hipec therapy for colon cancer metastasis.
• Peritoneal carcinomatosis in gastric cancer prior to neoadjuvent treatment for HIPC therapy (2).
• Peritoneal carcinomatosis in gastric cancer prior to neoadjuvent treatment for HIPC therapy (3).
• Peritoneal carcinomatosis in gastric cancer prior to neoadjuvent treatment for HIPC therapy.